Changes in the Choroidal Thickness following Intravitreal Bevacizumab Injection in Chronic Central Serous Chorioretinopathy. | J Clin Med;11(12)2022 Jun 13. | MEDLINE

Main content 1 Search 2 Footer 3

+A A -A High contrast

VHL Regional Portal

Information and Knowledge for Health

Advanced Search EVID@Easy

Changes in the Choroidal Thickness following Intravitreal Bevacizumab Injection in Chronic Central Serous Chorioretinopathy.

Chung, Yoo-Ri; Lee, Su Jeong; Song, Ji Hun.

Affiliation

Chung YR; Department of Ophthalmology, Ajou University School of Medicine, Suwon 16499, Korea.
Lee SJ; Department of Ophthalmology, Ajou University School of Medicine, Suwon 16499, Korea.
Song JH; Department of Ophthalmology, Ajou University School of Medicine, Suwon 16499, Korea.

J Clin Med ; 11(12)2022 Jun 13.

Article in En | MEDLINE | ID: mdl-35743446

Key words

bevacizumab; central serous chorioretinopathy; choroidal thickness

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Type of study: Risk_factors_studies Language: En Journal: J Clin Med Year: 2022 Document type: Article Country of publication:

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Type of study: Risk_factors_studies Language: En Journal: J Clin Med Year: 2022 Document type: Article Country of publication: